Sanofi 2Q: Dupixent's First Set Of Sales Are On Track

Railway
Sanofi's newly launched eczema drug Dupixent is on track after a solid quarter • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business